Goodrx Holdings Inc (GDRX)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.20B
Last updated: Nov 17, 2026 at 4:15 PM ET
Goodrx Holdings Inc (GDRX) Statistics
Goodrx Holdings (GDRX) has a market cap of $1.20B and an enterprise value of $1.39B. Its share count is down 4.86% from a year earlier. Its return on invested capital of 4.33% compares with a 1.43% median across 8 similar companies.
Total Valuation
Enterprise value is 15.91% above the market cap, as debt exceeds cash.
| Market Cap | $1.20B |
|---|---|
| Enterprise Value | $1.39B |
| Latest price (Nov 17, 2026) | $3.47 |
Key Dates
The next earnings report is set for Nov 17, 2026.
| Next Earnings Date | Nov 17, 2026 |
|---|---|
| Last Earnings Date | Nov 17, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.5x and 1.8x. Its year-end P/E ranged from 7.7x to 99.0x from 2021 to 2025.
| P/E Ratio | 14.5x |
|---|---|
| Forward P/E | 11.2x |
| P/S Ratio | 1.5x |
| Forward P/S | 1.5x |
| P/B Ratio | 1.8x |
| P/TBV Ratio | 62.9x |
| P/FCF Ratio | 8.9x |
| P/OCF Ratio | 5.9x |
| PEG Ratio | 0.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 8.2x EBITDA and 10.4x free cash flow.
| EV / Earnings | 85.4x |
|---|---|
| EV / Sales | 1.8x |
| EV / EBITDA | 8.2x |
| EV / EBIT | 18.4x |
| EV / FCF | 10.4x |
Price Statistics
The stock is up 16.84% over 52 weeks and trades 0.87% above its 50-day average.
| Beta (1Y) | 1.38 |
|---|---|
| 52-Week Change | +16.84% |
| 1-Month Change | +2.97% |
| 3-Month Change | -1.98% |
| 6-Month Change | +37.70% |
| 5-Year Change | -92.17% |
| Total Return (1Y) | +16.84% |
| Total Return (3Y CAGR) | -12.78% |
| Total Return (5Y CAGR) | -38.96% |
| Return vs SPY (1Y) | +12.81% |
| Max Drawdown (1Y) | -35.52% |
| Max Drawdown (3Y) | -79.34% |
| Sharpe Ratio (1Y) | 0.39 |
| Correlation with SPY (1Y) | 0.34 |
| 50-Day Average | $3.44 |
| 200-Day Average | $2.88 |
| 52-Week Range | $1.77 to $3.89 |
| RSI (14 Days) | 48.2 |
| Average Volume (20 Days) | 1.14M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.38x current liabilities, and total debt is 0.75x shareholder equity.
| Current Ratio | 1.38x |
|---|---|
| Quick Ratio | 1.38x |
| Debt / Equity | 0.75x |
| Debt / EBITDA | 2.93x |
| Debt / FCF | 3.69x |
| Interest Coverage | 1.85x |
Returns and Efficiency
Return on invested capital is 4.33% over the last 12 months, against a 5-year average of 1.63%.
| Return on Equity (ROE) | 2.51% |
|---|---|
| Return on Assets (ROA) | 0.69% |
| Return on Invested Capital (ROIC) | 4.33% |
| Return on Capital Employed (ROCE) | 6.38% |
| ROE (5Y Average) | -0.21% |
| ROA (5Y Average) | -0.17% |
| ROIC (5Y Average) | 1.63% |
| Asset Turnover | 0.43x |
| Receivables Turnover | 3.79x |
Taxes
Income tax took 60.75% of pretax income over the last 12 months.
| Income Tax (TTM) | $25.15M |
|---|---|
| Effective Tax Rate | 60.75% |
Scores
GDRX has an Altman Z-Score of 0.25, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.25 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $785.23M over the last 12 months is down 1.83% from the 12 months before.
| Revenue | $785.23M |
|---|---|
| Revenue Growth (YoY) | -1.83% |
| Gross Profit | $713.19M |
| Operating Income | $74.94M |
| Pretax Income | $41.40M |
| Net Income | $16.25M |
| EBITDA | $166.04M |
| EBIT | $75.57M |
| Reported EPS (TTM) | $0.24 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 27.68% of the $2.34B in total assets.
| Cash and Equivalents | $296.11M |
|---|---|
| Total Debt | $486.59M |
| Net Debt | $190.47M |
| Net Debt Per Share | $0.56 |
| Working Capital | $441.46M |
| Shareholder Equity | $647.60M |
| Book Value Per Share | $1.91 |
| Tangible Book Value | $18.72M |
| Tangible Book Per Share | $0.06 |
| Total Assets | $2.34B |
| Total Liabilities | $1.70B |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $69.88M of capital spending, operating cash flow left $131.70M of free cash flow.
| Operating Cash Flow | $201.58M |
|---|---|
| Capital Expenditures | $69.88M |
| Free Cash Flow | $131.70M |
| FCF Per Share | $1.23 |
| Depreciation and Amortization | $90.47M |
| Share Repurchases | $85.00M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is 9.54%, against a 5-year average of 3.54%.
| Gross Margin | 90.83% |
|---|---|
| Operating Margin | 9.54% |
| Pretax Margin | 5.27% |
| Net Margin | 2.07% |
| EBITDA Margin | 21.15% |
| EBIT Margin | 9.62% |
| FCF Margin | 16.77% |
| Gross Margin (5Y Average) | 92.60% |
| Operating Margin (5Y Average) | 3.54% |
| Net Margin (5Y Average) | -0.59% |
Growth
Revenue grew 1.30% a year over 3 years, and EPS 5.27% a year.
| Revenue Growth (3Y CAGR) | +1.30% |
|---|---|
| Revenue Growth (5Y CAGR) | +7.67% |
| EPS Growth (3Y CAGR) | +5.27% |
| EPS Growth (5Y CAGR) | -61.77% |
| FCF Growth (3Y CAGR) | +0.84% |
| FCF Growth (5Y CAGR) | -0.34% |
| Operating Income Growth (3Y CAGR) | +269.24% |
| Book Value Per Share Growth (2Y CAGR) | -2.54% |
Dividends and Yields
GDRX does not pay a dividend. Its free cash flow yield is 11.19%.
| Earnings Yield | 6.90% |
|---|---|
| FCF Yield | 11.19% |
| Buyback Yield | 7.18% |
| Shareholder Yield | 7.18% |
Peer Position
Against 8 similar companies, GDRX has the 7th highest P/E and the 3rd highest ROIC.
P/E RatioPeer median 34.9x
P/S RatioPeer median 2.0x
ROICPeer median 1.43%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.73%
| P/E Ratio | 14.5x vs 34.9x median |
|---|---|
| P/S Ratio | 1.5x vs 2.0x median |
| ROIC | 4.33% vs 1.43% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -1.83% vs +7.73% median |
Analyst Forecast
Consensus estimates put revenue growth at 2.44% and EPS growth at 0.29% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2.44% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +0.29% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GDRX
What is GDRX's market cap?
Goodrx Holdings has a market cap of $1.20B. Its enterprise value, which adds debt and subtracts cash, is $1.39B.
What is GDRX's P/E ratio?
Goodrx Holdings has a trailing P/E ratio of 14.5x and a forward P/E of 11.2x.
How many shares of GDRX are outstanding?
Goodrx Holdings has 339.28M shares outstanding. The count is down 4.86% from a year earlier.
Does GDRX pay a dividend?
No. Goodrx Holdings does not pay a dividend.
How much debt does GDRX have?
Goodrx Holdings has $486.59M of total debt and $296.11M of cash and equivalents, a net debt position of $190.47M.
GDRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors